Subcutaneous Infusion of Pamidronate in a Hospice Patient with Hypercalcemia: A Case Report.
作者信息
Vandevelde Chris, Ho Jordan
机构信息
, BScPharm, ACPR, is a Clinical Pharmacy Specialist in the Palliative Care Program (Fraser East), Fraser Health Authority, Abbotsford, British Columbia.
, BScPharm, is a Clinical Pharmacist with the Fraser Health Authority, Surrey, British Columbia.
出版信息
Can J Hosp Pharm. 2021 Winter;74(1):80-82. Epub 2021 Jan 1.
Abstract
摘要
相似文献
1
Subcutaneous Infusion of Pamidronate in a Hospice Patient with Hypercalcemia: A Case Report.皮下输注帕米膦酸盐治疗临终关怀患者高钙血症：一例报告
Can J Hosp Pharm. 2021 Winter;74(1):80-82. Epub 2021 Jan 1.
2
Severe hypercalcemia associated with Williams syndrome successfully treated with pamidronate infusion therapy.与威廉姆斯综合征相关的严重高钙血症经帕米膦酸输注治疗成功治愈。
J Pediatr Endocrinol Metab. 2011;24(1-2):69-70. doi: 10.1515/jpem.2011.113.
3
Effectiveness of pamidronate in severe neonatal hypercalcemia caused by subcutaneous fat necrosis: a case report.帕米膦酸治疗皮下脂肪坏死所致重症新生儿高钙血症的有效性：一例报告
Eur J Pediatr. 2009 May;168(5):625-7. doi: 10.1007/s00431-008-0797-8. Epub 2008 Aug 23.
4
Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone.
Arch Intern Med. 1994 Sep 12;154(17):1935-44. doi: 10.1001/archinte.154.17.1935.
5
Safety and Efficacy of Pamidronate in Neonatal Hypercalcemia Caused by Subcutaneous Fat Necrosis: A Case Report.帕米膦酸治疗皮下脂肪坏死所致新生儿高钙血症的安全性和有效性：一例报告
Front Pediatr. 2022 Apr 28;10:845424. doi: 10.3389/fped.2022.845424. eCollection 2022.
6
The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.帕米膦酸盐用于急性维生素D中毒继发的高钙血症。
J Toxicol Clin Toxicol. 1998;36(7):719-21. doi: 10.3109/15563659809162621.
7
Use of Pamidronate to Treat Hypercalcemia in an Oncology Dialysis Patient: A Case Report.使用帕米膦酸盐治疗肿瘤透析患者的高钙血症：一例报告
Am J Case Rep. 2018 Sep 13;19:1087-1089. doi: 10.12659/AJCR.908605.
8
Pamidronate as first-line treatment of hypercalcemia in neonatal subcutaneous fat necrosis: A case series.帕米膦酸作为新生儿皮下脂肪坏死高钙血症的一线治疗：病例系列
Paediatr Child Health. 2019 Dec 24;26(1):e52-e56. doi: 10.1093/pch/pxz141. eCollection 2021 Feb.
9
Use of Pamidronate for Hypercalcemia of Malignancy in Renal Dysfunction.帕米膦酸二钠在肾功能不全的恶性肿瘤高钙血症中的应用。
J Pharm Pract. 2021 Aug;34(4):553-557. doi: 10.1177/0897190019883162. Epub 2019 Oct 24.
10
Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.静脉注射单剂量帕米膦酸治疗恶性肿瘤高钙血症：30毫克、60毫克和90毫克剂量的比较
Am J Med. 1993 Sep;95(3):297-304. doi: 10.1016/0002-9343(93)90282-t.
本文引用的文献
1
Prevalence of hypercalcemia among cancer patients in the United States.美国癌症患者高钙血症的患病率。
Cancer Med. 2016 Aug;5(8):2091-100. doi: 10.1002/cam4.749. Epub 2016 Jun 5.
2
Cancer-Related Hypercalcemia.癌症相关高钙血症
J Oncol Pract. 2016 May;12(5):426-32. doi: 10.1200/JOP.2016.011155.
3
Hypercalcemia of Malignancy: An Update on Pathogenesis and Management.恶性肿瘤高钙血症：发病机制与管理的最新进展
N Am J Med Sci. 2015 Nov;7(11):483-93. doi: 10.4103/1947-2714.170600.
4
Clinical practice. Hypercalcemia associated with cancer.临床实践。癌症相关的高钙血症。
N Engl J Med. 2005 Jan 27;352(4):373-9. doi: 10.1056/NEJMcp042806.
5
Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration.皮下注射氯膦酸盐的安全性及对恶性肿瘤高钙血症的疗效：一种新的给药途径。
J Pain Symptom Manage. 2003 Sep;26(3):843-8. doi: 10.1016/s0885-3924(03)00252-5.
6
The use of subcutaneous pamidronate.皮下注射帕米膦酸盐的应用。
J Pain Symptom Manage. 2003 Jul;26(1):592-3. doi: 10.1016/s0885-3924(03)00225-2.
7
Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity.皮下注射氯膦酸盐：一项评估其对恶性肿瘤高钙血症疗效及局部毒性的研究。
Ann Oncol. 1997 Sep;8(9):915-6. doi: 10.1023/a:1008274608267.
8
Hypercalcemia of malignancy in the palliative care patient: a treatment strategy.姑息治疗患者的恶性肿瘤高钙血症：一种治疗策略。
J Pain Symptom Manage. 1995 Apr;10(3):224-32. doi: 10.1016/0885-3924(94)00127-7.
Zotero 插件